According to a recent study, an AI model has been found to be effective in screening melanoma and other skin cancers.
Combination dupilumab, abrocitinib effective in treating refractory pediatric AD
According to a recent study, a combination of dupilumab and abrocitinib is effective in treating refractory atopic dermatitis (AD) in pediatric patients.
Cosmetic regimen effectively treats skin redness in rosacea
According to a recent study, a cosmetic regimen of a treatment serum, redness-reducing moisturizer, and sunscreen was effective in reducing redness and improving skin appearance.
Study shows ferulic acid effective as adjuvant treatment for papulopustular rosacea
According to a recent study, topical ferulic acid is effective as an adjuvant treatment for papulopustular rosacea.
New study links stress and psoriasis relapse
According to a recent study, perceived stress can trigger the relapse of psoriatic skin lesions. The study was presented at the European Academy of Dermatology and Venereology Congress in Amsterdam (Sept. 27, 2024).
Home-based narrowband UV-B phototherapy for PsO as effective as office-based treatment
According to a recent study, home-based narrowband UV-B phototherapy for plaque and guttate psoriasis is as effective as office-based treatments.
Exclusive content available for ISSS and SSS attendees
The Indigenous Skin Spectrum Summit will be held on Friday, Oct. 4, followed by the Skin Spectrum Summit on Saturday, Oct. 5.
Veterans are more at risk for psoriasis, skin cancer
According to a recent study, U.S. veterans are more likely to have a history of skin cancer, melanoma, and psoriasis when compared to non-veterans.
Risk of pediatric AD associated with childhood obesity
According to a recent study, risk of pediatric atopic dermatitis (AD) is associated with childhood obesity and correlated to weight loss and gain.
Extended guselkumab dosing effective for PsO super responders
According to a recent study, extending the dosing interval of guselkumab from eight weeks to sixteen weeks is non-inferior for treating moderate-to-severe psoriasis in super-responders.
HealthMinute.TV 